版本:
中国

BRIEF-Supernus announces settlement with Actavis on Trokendi XR patent litigation

March 7 Supernus Pharmaceuticals Inc

* Supernus announces settlement with Actavis on Trokendi XR patent litigation

* Patent protection for Trokendi XR expires no earlier than 2027

* Settlement permits Actavis to begin selling generic version of Trokendi XR on Jan 1, 2023, or earlier under certain circumstances Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐